Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Human Antibodies is Scopus-indexed (Q3, CiteScore 2.4). It is covered by India's One Nation One Subscription scheme for reading access. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1093-2607Verify ISSN ↗1875-869XVerify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: About US$4,150 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 169 / 234 | 27th | Q3 |
| Immunology | 185 / 243 | 24th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present (also 1999–2013, 1990–1997), best quartile Q3, CiteScore 2.4.
Human Antibodies is Q3 in Immunology and Allergy (rank 169 of 234) and Q4 in Immunology (rank 185 of 243), by CiteScore 2025.
Human Antibodies is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 2.4, quartile Q3, 27th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.363, quartile Q3, with an H-index of 29.
The publisher lists an article processing charge of about US$4,150 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Human Antibodies is published by SAGE Publications Ltd. Its print ISSN is 1093-2607 and its online ISSN is 1875-869X.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Human Antibodies has an h-index of 35 and a 2-year mean of 3.05 citations per paper (OpenAlex). Its Scopus CiteScore is 2.4, quartile Q3. On 2-year citations it ranks #83 of 231 Scopus journals in Immunology and Allergy.
Human Antibodies published 11 papers in 2025; its busiest recent year was 2019 with 42. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 81 research articles (2021–2025), authors are most often from Iraq (35.4%), Iran (24.9%) and Türkiye (7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.